Interim data for fadraciclib monotherapy in patients with advanced solid tumors preselected for CDKN2A and/or CDKN2B abnormalities -BERKELEY HEIGHTS, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel ...
CHRISTUS Mother Frances Hospital – Tyler is proud to announce the 100th successful procedure using the Intuitive Ion Robotic Bronchoscope, the newest state-of-the-art system for early detection of ...
Under Indaptus' clinical supply agreement with BeiGene, the New York biotechnology company plans to advance human clinical evaluation of its cancer treatment -- called Decoy20, which is being studied ...